ACT EU is developing a training curriculum informed by regulatory experience to support high quality clinical trials and enable better knowledge sharing.
An overarching strategy and collection of training needs for different stakeholders will serve as the basis for the development of curricula.
Engaging with stakeholders, the curriculum aims to feed into an educational ‘ecosystem’ to enable targeted training on clinical trials.
Survey on clinical trials training needs of academia and SMEs
Stakeholders from academia or SMEs involved in the development of medicines for human use were invited to share their clinical trial training needs via a survey until 11 February 2025.
The identified training needs may also highlight potential gaps. An overview will be published later in 2025.
Related documents
A training strategy is available, setting out high-level objectives for the development of a training curriculum. The document highlights the importance of accessing appropriate expertise in medicines development.
A summary of the gap analysis on training needs of regulators involved in clinical trial assessment is also available.
